ANIP

ANI Pharmaceuticals, Inc.

Health Care
51
/100
HOLD
Signal 2.0 composite score — 7-pillar quant rating updated daily.

Signal 2.0

7-Pillar Score Breakdown

Each pillar scores 0–100. The composite is a regime-weighted blend of all seven.

Fundamentals & Quality
60
Valuation
85
Technicals & Momentum
40
Sentiment & News
2
Earnings Quality
79
Risk Profile
54
Market Regime
52

Premium Insights

Deeper Analysis — Unlocking Soon

Advanced institutional-grade signals are coming to Quantex Premium. Join the waitlist for early access.

Institutional Flow Signal ★ PREMIUM
🔒 PREMIUM Unlock with Premium
Earnings Risk Score ★ PREMIUM
73
Risk Score / 100
MODERATE
EPS Beat Est.
Report in ~14 days
🔒 PREMIUM Unlock with Premium

Fundamentals

Key Metrics

Sourced from the daily universe scan. Open the terminal for the full financial deep-dive.

Market Cap
$1.9B
P/E Ratio
21.0x
Revenue Growth
+30.7%
EPS Growth
+86.1%
Profit Margin
10.0%
Beta
0.43

See the full picture for ANIP.

Run live Signal 2.0 scoring, deep financial statements, DCF valuation, CAPM, and options pricing — free, no account required.

Open Full Analysis → Browse All Stocks